Alterity Therapeutics (ATHE) Other Accumulated Expenses (2019 - 2025)

Alterity Therapeutics' Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $89.29 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses fell 7.11% year-over-year to $89.29; the TTM figure through Dec 2025 stood at $89.29 (down 7.11% YoY), while the FY2025 annual figure was $89.02, down 99.86% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $89.29, roughly flat from $89.02 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $116587.2 in Q4 2023, with the low at $89.02 in Q2 2025.
• The 5-year median for Other Accumulated Expenses is $16207.6 (2021), against an average of $30286.6.
• The sharpest annual moves came in 2022 and 2024: Other Accumulated Expenses jumped 259.09% in 2022, then tumbled 99.92% in 2024.
• Alterity Therapeutics' Other Accumulated Expenses stood at $11049.2 in 2021, then surged by 259.09% to $39676.2 in 2022, then surged by 193.85% to $116587.2 in 2023, then sank by 99.92% to $96.13 in 2024, then decreased by 7.11% to $89.29 in 2025.
• Business Quant data shows ATHE's Other Accumulated Expenses at $89.29 in Q4 2025, $89.02 in Q2 2025, and $96.13 in Q4 2024.